Table 2. The association between statins and 30-day mortality following MAARI.

	ORa	95% CIb	P-Value
Crude	1.55	1.34–1.81	<0.001
Model Ac	0.67	0.54–0.83	<0.001
Model Bd	0.63	0.51–0.78	<0.001
Model Ce	0.65	0.52–0.80	<0.001

Notes.

^aOdds Ratio

^bConfidence Interval

^cAdjusted for a priori confounders, all comorbidity variables, all drug covariate variables, all potential confounding variables

^dAdjusted for a priori confounders, variables significantly associated with both outcome and exposure (≤0.05)

^eAdjusted for a priori confounders, variables significantly associated with both outcome and exposure and altering the crude OR by ≥10%

Variables included in models A, B and C detailed in Appendix S2

Significant P- values shown in bold